Actually, we found c-Met expression could predict potential ASCs susceptibility of breast cancer cells, since we found a strong c-Met positivity in breast cancers of human donors displaying a recurrent pathology after fat grafts and a weak/moderate staining in patients which did not display any sign of recurrence after fat grafts (Figure 8C). The gene discussed is MET; the disease is breast carcinoma.